Skip to main content
. 2019 Dec 10;14(12):e0226292. doi: 10.1371/journal.pone.0226292

Table 2. Characteristics of the studies included for the meta-analysis of omentin-1 concentrations in diabetes mellitus.

Study Study design Male, n(%) BMI Mean Age Type Methods Frozen NOS
Abd-elbaky 2015 Case-control 80(100%) 32.4±1.4 42.0±3.0 T2DM ELISA −80℃ 7
Abdelraoufkorany 2018 Case-control 12(48%) 26.6±2.9 56.5±7.2 T2DM ELISA NR 6
Abell 2017 Case-control 25(0%) 28.0±2.6 32.7±3.3 GDM ELISA −80℃ 7
Ahmed 2018 Case-control 40(100%) 28.8±6.8 57.6±15.6 T2DM ELISA −20℃ 8
Akbarzadeh 2012 Case-control 41(46%) 27.6±4.3 40.5±9.6 T2DM ELISA −70℃ 7
Akour 2016 Case-control 68(66%) 33.3±3.0 51.0±4.8 T2DM ELISA −80℃ 8
Cai 2008 Case-control 35(51%) 28.5±2.7 48.8±11.7 T2DM ELISA −80℃ 8
Dayem 2015 Case-control 62(100%) 24.9±4.2 16.3±1.5 T1DM ELISA NR 6
El-mesallamy 2011 Case-control 35(66%) 29.0±0.8 58.0±1.0 T2DM ELISA −80℃ 7
Elsaid 2018 Case-control 60(0%) 39.4±7.0 49.5±6.0 T2DM ELISA −20℃ 8
Franz 2018 Case-control 96(0%) 28.0±6.6 34.1±7.4 GDM ELISA −80℃ 9
Greulich 2013 Case-control 78(100%) 28.9±1.1 71.9±2.4 T2DM ELISA −80℃ 7
Hayashi 2018 Case-control 246(58%) 25.0±2.2 65.0±5.7 T2DM ELISA NR 5
Herder 2017 Case-control 34(52%) 27.7±4.0 68.6±4.9 T2DM ELISA NR 6
Kahwaji 2017 Cross sectional 35(34%) 33.5±5.9 51.9±10.9 T2DM ELISA −80℃ 7
Kocijancic 2015 Case-control 57(34%) 25.6±3.7 70.0±3.0 T2DM ELISA NR 6
Lewandowski 2010 Case-control 20(100%) 30.3±3.1 29.7±3.7 GDM ELISA NR 6
Madsen 2015 Case-control 3(30%) 27.6±2.7 56.0±2.0 T2DM ELISA −80℃ 7
Mierzyński 2018 Case-control 63(0%) 24.8±2.5 28.6±5.1 GDM ELISA −70℃ 8
Motawi 2017 Case-control 23(51%) 23.1±1.8 53.7±7.6 T2DM ELISA NR 6
Nurten 2018 Case-control 115(47%) 23.9±9.2  13.0±3.9  T1DM ELISA −80℃ 7
Pan 2010 Case-control 30(55%) 25.9±3.3 39.9±4.8 T2DM ELISA −70℃ 7
Polkowska 2016 Case-control 5(50%) 18.3±5.7 10.4±2.8 T1DM ELISA NR 6
Tan 2008 Case-control 19(100%) 25.1±3.3 30.3±4.9 T1DM ELISA NR 6
Tekce 2014 Case-control 36(66%) 26.1±4.8 55.2±8.9 T2DM ELISA −80℃ 8
Tsiotra 2018 Case-control 15(100%) 36.0±1.5 36.1±1.2 GDM ELISA −80℃ 7
Urbanova 2014 Case-control 11(0%) 52.6±2.6 56.9±2.8 T2DM ELISA −80℃ 6
Wan 2015 Case-control 60(100%) 23.8±3.0 58.7±9.0 T2DM ELISA −80℃ 7
Yan 2011A Case-control 18(51%) 24.3±0.6 55.5±1.7 T2DM ELISA −70℃ 7
Yan 2011B Case-control 13(43%) 24.4±3.3 53.1±7.7 T2DM ELISA −80℃ 7
Yoo 2011 Case-control 10(33%) 23.9±2.3 53.1±6.8 T2DM ELISA −80℃ 7
Zhang 2014 Case-control 20(57%) 32.4±5.5 65.1±10.7 T2DM ELISA −80℃ 8
Abd El Dayem 2015 Case-control 31(50%) 24.9±4.2 16.3±1.5 T1DM ELISA NR 7
Nassif 2013 Case-control 19(87%) 24.3±0.3 48.9±1.5 T2DM ELISA −80℃ 5
Matloch 2018 Case-control 7(78%) 30.4±3.59 67.0±8.76 T2DM ELISA −80℃ 5
Gürsoy 2010 Case-control 0(0%) 30.5±4.8 52.8±10.7 T2DM ELISA −75℃ 6
Flehmig 2014 Cross sectional 34(50%) 46.9±10.1 53.0±13.0 T2DM ELISA NR 7
Dogan 2016 Case-control 7(47%) 22.8±1.9 48.3±6.1 T2DM ELISA −80℃ 5
Komosinska-vassev 2019 Case-control 23(55%) 33.1±4.1 61.0±5.6 T2DM ELISA −20℃ 7
Rathwa 2019 Case-control 123(49%) 28.2±5.0 55.9±10.5 T2DM ELISA −20℃ 7
Tuttolomondo 2019 Case-control 23(57%) 29.4±5.5 61.4±11.4 T2DM ELISA −80℃ 6
Souvannavong-vilivong 2019 Case-control 0(0%) 29.0±5.0 38.2±1.3 GDM ELISA −70℃ 6

Characteristics of eligible studies are shown in each independent case. NOS, Newcastle-Ottawa Scale; BMI, Body Mass Index; ELISA, enzyme linked immunosorbent assay; NR, not report; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; GDM, gestational diabetes mellitus.